| Cetrotide (cetrorelix) / EMD Serono |
| Completed | 3 | 136 | Europe | Cetrorelix acetate, Cetrotide®, Recombinant Human Choriogonadotropin (r-hCG), Ovitrelle®, Recombinant human follicle stimulating hormone (r-hFSH) | Merck KGaA, Darmstadt, Germany, Merck Serono S.A.S, France | Polycystic Ovarian Syndrome | 10/11 | 02/12 | | |
NCT01268761: GnRH Antagonist for Treatment of Early Ovarian Hyperstimulation Syndrome |
|
|
| Completed | 3 | 100 | Europe | GnRH antagonist (Cetrorelix), Placebo (saline solution) | Instituto Valenciano de Infertilidad, IVI VALENCIA | Ovarian Hyperstimulation Syndrome, Effects of Gonadotropin, Oocyte Maturation | 07/13 | 07/13 | | |
NCT01709942: Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS) |
|
|
| Completed | 3 | 80 | Europe | degarelix (long acting GnRH antagonist), Firmagon, cetrorelix 0.25mg, cetrotide | Centre for Endocrinology and Reproductive Medicine, Italy | PCOS, OHSS, INFERTILITY | 12/15 | 12/15 | | |
NCT01402336: GnRH Antagonist Versus GnRH Agonist in Polycystic Ovary Syndrome During in Vitro Fertilization - Embryo Transfer |
|
|
| Completed | 3 | 43 | RoW | GnRH antagonist (Cetrorelix), Cetrotide, Conventional GnRH agonist (Triptorelin), Decapeptyl | Seoul National University Hospital | Infertility, Polycystic Ovary Syndrome | 12/16 | 12/16 | | |
